Synergistic effects on blending multiple additives in uhmwpe
US-2017137603-A1 · May 18, 2017 · US
US12350403B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12350403-B2 |
| Application number | US-201615774860-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 10, 2016 |
| Priority date | Nov 12, 2015 |
| Publication date | Jul 8, 2025 |
| Grant date | Jul 8, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Therapeutic polymeric materials, therapeutic polymeric materials containing medical implants and methods for making the same, and related materials are described. Methods of making medical implants containing additives/antibiotics, therapeutic polymers, and materials used therewith also are described. Methods of spatially controlling additive/antibiotic concentrations, non-homogenous distribution of therapeutic agents in polymeric materials and therapeutic medical implants containing layered constructs of polymeric materials are provided. Therapeutic medical implants containing incorporated therapeutic agents in the polymeric materials, for example, antibiotics into polymeric total joint implants, are useful for delivery of the therapeutic agents into the surrounding mediums.
Opening claim text (preview).
What is claimed is: 1. A method of making an antibiotic-eluting implantable medical device comprising: a. providing a first UHMWPE (ultra-high molecular weight polyethylene) and a second UHMWPE; b. blending the first UHMWPE with about 6 wt % to about 8 wt % gentamicin; c. layering the first UHMWPE blended with gentamicin with the second UHMWPE without gentamicin to form a layered UHMWPEs; d. direct compression molding the layered UHMWPEs, thereby obtaining the antibiotic-eluting implantable medical device, wherein the medical device is not permanent and removed after use, and wherein the implanted medical device elutes the antibiotic for at least 36 weeks. 2. A method of making an antibiotic-eluting implantable medical device comprising: a. providing a first UHMWPE (ultra-high molecular weight polyethylene) and a second UHMWPE; b. blending the first UHMWPE with about 6 wt% to about 8 wt% gentamicin to form a first blended UHMWPE; c. layering the first blended UHMWPE with the second UHMWPE without gentamicin to form a layered UHMWPEs; d. direct compression molding the layered UHMWPEs, thereby obtaining the antibiotic-eluting implantable medical device, wherein the medical device is not permanent and removed after use, and wherein the implanted medical device elutes the antibiotic for at least 36 weeks. 3. A method of making an antibiotic-eluting implantable medical device comprising: a. providing a first UHMWPE (ultra-high molecular weight polyethylene); b. blending the UHMWPE with about 6 wt % to about 8 wt % gentamicin to form the first blended UHMWPE; c. providing a second UHMWPE; d. blending the second UHMWPE with di-cumyl peroxide to form the second blended UHMWPE; e. layering the first and the second blended UHMWPEs to form a layered UHMWPEs; f. consolidating the layered UHMWPEs, thereby obtaining the antibiotic-eluting implantable medical device, wherein the medical device is not permanent and removed after use, and wherein the implanted medical device elutes the antibiotic for at least 36 weeks. 4. The method according to claim 1 , wherein the first and the second UHMWPEs are pre-mixed with antioxidant. 5. The method according to claim 1 , wherein the antibiotic-eluting implantable medical device is a tibial insert. 6. The method according to claim 5 , wherein the tibial insert is packaged and sterilized. 7. A method of making a tibial insert comprising: a. providing a first UHMWPE (ultra-high molecular weight polyethylene) and a second UHMWPE; b. blending the first UHMWPE with about 6 wt % to about 8 wt % gentamicin; c. layering the first UHMWPE blended with gentamicin with the second UHMWPE without gentamicin to form a layered UHMWPEs; d. direct compression molding the layered UHMWPEs, thereby obtaining the tibial insert, wherein the tibial insert is not permanent and removed after use, and wherein the implanted tibial insert elutes the antibiotic for at least 36 weeks. 8. A method of making an antibiotic-eluting implantable medical device comprising: a. providing a UHMWPE (ultra-high molecular weight polyethylene); b. blending UHMWPE with about 6 wt % to about 8 wt % gentamicin; and c. direct compression molding the gentamicin-blended UHMWPE, thereby obtaining the antibiotic-eluting implantable device, wherein the medical device is not permanent and removed after use, and wherein the implanted medical device elutes the antibiotic for at least 36 weeks.
for joint reconstruction · CPC title
Coatings comprising two or more layers · CPC title
Coatings containing a mixture of two or more compounds · CPC title
Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases · CPC title
Methods for coating medical devices · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.